Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Nicholas Z. Kerin"'
Autor:
Nicholas Z. Kerin
Publikováno v:
Cardiology. 140(3)
The pharmacologic treatment of arrhythmias has seen little advance over the past few years. Physicians treating life threatening or hemodynamically destabilizing arrhythmias depend almost entirely on intravenous (IV) amiodarone. This is regrettable d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::293114e58726203a03546fe0d26dfc77
https://pubmed.ncbi.nlm.nih.gov/30016794
https://pubmed.ncbi.nlm.nih.gov/30016794
Publikováno v:
American Journal of Therapeutics. 18:241-260
Atrial fibrillation (AF) is one of the most common arrhythmia encountered in clinical practice. Although AF is due to the structural and electrophysiological alterations in the atria, its sustainability is multifactorial, and the actual mechanisms ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b713720106915b1598ccf933080ed743
https://doi.org/10.1097/mjt.0b013e3181eea7c5
https://doi.org/10.1097/mjt.0b013e3181eea7c5
Autor:
Janos Molnar, Steven J. Bailin, John C. Somberg, Jozsef Borbola, Walter P Paladino, Istvan Sarosi, Sandor Timar, Jeno Tarjan, Ferenc Lakatos, Duane E. Bridges, Nicholas Z. Kerin, Charles I. Haffajee
Publikováno v:
The American Journal of Cardiology. 93:576-581
Hypotension is the most frequent adverse event reported with intravenous amiodarone. Hypotension has been attributed to the vasoactive solvents of the standard formulation (Cordarone IV) and is not dose related, but related to the rate of infusion. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032f0bcd9801ff98236706c40fe9685b
https://doi.org/10.1016/j.amjcard.2003.11.021
https://doi.org/10.1016/j.amjcard.2003.11.021
Autor:
Walter P Paladino, Janos Molnar, Duane E. Bridges, Nicholas Z. Kerin, Charles I. Haffajee, Sandor Timar, John C. Somberg, Steven J. Bailin
Publikováno v:
The American Journal of Cardiology. 90:853-859
The effectiveness of intravenous amiodarone for the treatment of incessant (shock resistant) ventricular tachycardia (VT) has not been established. This study evaluated the efficacy of a water-soluble amiodarone preparation or lidocaine for the treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a8266c2325eda34d856df4f0b66b22
https://doi.org/10.1016/s0002-9149(02)02707-8
https://doi.org/10.1016/s0002-9149(02)02707-8
Publikováno v:
American Journal of Therapeutics. 5:59-66
The purpose of this study was to investigate the effect of multiple doses of orally administered isradipine on atrioventricular nodal conduction in patients with first-degree atrioventricular block. Forty-eight patients with a P-R interval > or =0.22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b472410fb994d233343734db2a598e55
https://doi.org/10.1097/00045391-199803000-00002
https://doi.org/10.1097/00045391-199803000-00002
Autor:
H. E. Haber, Gerald C. Timmis, Robert Singer, William L. Meengs, David Salerno, Nicholas Z. Kerin
Publikováno v:
Cardiovascular Drugs and Therapy. 11:169-175
Procainamide is a class IA antiarrhythmic drug indicated for the treatment of life-threatening or symptomatic ventricular arrhythmias. The current sustained-release formulation requires 6-hour dosing (qid). To improve patient compliance, a new sustai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1382e68fa4f861da8f6f6d6787f52f3a
https://doi.org/10.1023/a:1007736931662
https://doi.org/10.1023/a:1007736931662
Autor:
Nicholas Z. Kerin, Kathy Faitel
Publikováno v:
American Journal of Therapeutics. 3:225-228
The effectiveness of an antiarrhythmic drug is judged by the degree of ventricular arrhythmia suppressed by the drug. It has been suggested that a certain degree of ventricular arrhythmia suppression should be targeted to prove efficacy. Targets used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5fe8542aef4cd338943657b9ef7a46
https://doi.org/10.1097/00045391-199603000-00008
https://doi.org/10.1097/00045391-199603000-00008
Autor:
John C. Somberg, Nicholas Z. Kerin
Publikováno v:
American Heart Journal. 128:575-585
“Proarrhythmia” or “arrhythmogenicity” indicates the capacity of a cardiac or noncardiac drug to aggravate an existing arrhythmia or provoke a new arrhythmia at therapeutic or subtherapeutic levels. This definition excludes arrhythmias induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f57597fc4383993d80f2190855d65b4
https://doi.org/10.1016/0002-8703(94)90634-3
https://doi.org/10.1016/0002-8703(94)90634-3
Autor:
Nicholas Z. Kerin, Sony Jacob
Publikováno v:
The American journal of medicine. 124(9)
Objective Supraventricular tachyarrhythmias including atrial fibrillation are common and troubling complications after cardiac surgery, and thus considerable interest in pharmacologic prophylaxis has developed. The aim of this study was to evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df85738177d3ddd560c37a9e02a89100
https://pubmed.ncbi.nlm.nih.gov/21854895
https://pubmed.ncbi.nlm.nih.gov/21854895
Publikováno v:
American Heart Journal. 126:201-205
Proarrhythmic effects of nonantiarrhythmic drugs have not been as extensively studied or reported compared with the effects of antiarrhythmic drugs. The proarrhythmic incidence of many of these agents is not accurately known. In some instances, the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61e35bf8bd9fa82f9237422408a9772
https://doi.org/10.1016/s0002-8703(07)80029-9
https://doi.org/10.1016/s0002-8703(07)80029-9